跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,934 条关于
“Fibrodysplasia Ossificans Progressiva”
全部
3,934
临床试验
3,620
药物
7
机构
2
资讯
305
7个月前
FDA Grants Priority Review to Garetosmab for Ultra-Rare Bone Disease Fibrodysplasia Ossificans Progressiva
去年
āshibio Doses First Patient in Phase 2/3 Trial of Andecaliximab for Fibrodysplasia Ossificans Progressiva
去年
Regeneron's Garetosmab Achieves 90% Reduction in Bone Formation in Rare Disease Trial
去年
Incyte's ALK2 Inhibitor Zilurgisertib Fumarate Shows Promise Across Multiple Hematologic Disorders
去年
Incyte and iTeos Terminate Development of Zilurgisertib and Inupadenant Following Disappointing Trial Data
去年
Ipsen Advances Pipeline with Multiple Regulatory Wins and Strategic Partnerships in 2024
去年
Ipsen's Sohonos Becomes First Approved Treatment for FOP in Canada
3年前
AI Technology Revolutionizes Rare Disease Diagnosis, Reducing Detection Time by 4.4 Years
6个月前
Quotient Sciences Expands Manufacturing Partnership with Ipsen for Ultra-Rare FOP Treatment
去年
āshibio Licenses Vantictumab for Rare Bone Disease ADO2 in Strategic Pipeline Expansion
第 1 页，共 31 页
上一页
下一页
